An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
<p><b>Background:</b> The aim of this thesis was to develop an evidence-based approach to the post-marketing withdrawal of medicinal products when harms are attributed to their use. </p> <p><b>Methods:</b> Electronic and non-electronic searches were conducte...
第一著者: | Onakpoya, I |
---|---|
その他の著者: | Heneghan, C |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2017
|
主題: |
類似資料
-
Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
著者:: Stefania Chiappini, 等
出版事項: (2020-02-01) -
Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
著者:: Onakpoya, I, 等
出版事項: (2016) -
The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
著者:: Łukasz Dobrek
出版事項: (2022-08-01) -
Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
著者:: Onakpoya, IJ, 等
出版事項: (2016) -
Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
著者:: Igho J. Onakpoya, 等
出版事項: (2019-03-01)